NEWARK, Del., October 1, 2026 — According to Future Market Insights (FMI), the global Cold Plasma Market is projected to expand from USD 2,828.0 million in 2025 to USD 10,392.6 million by 2035, registering a 13.9% CAGR during the forecast period. Demand is being supported by medical sterilization requirements, interest in non-thermal wound-care technologies, and food-safety programs seeking chemical-free decontamination for packaging and fresh products.

FMI also identifies increasing demand for pharmaceutical packaging, advances in barrier-protection technologies, and rising regulatory compliance for drug safety and shelf-life extension as factors supporting cold-plasma demand. The report says cold plasma is moving beyond early technical applications toward broader medical and industrial use, including sterilization, wound healing, surface modification, food treatment, semiconductor processing, and sustainable industrial applications.

👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-12401

Global Segment Leaders

The current FMI page discusses the following segment leaders but does not publish percentage shares for these segments. Accordingly, no share has been estimated.

·         Regime Type — Low-pressure cold plasma: FMI identifies low-pressure systems as gaining traction where controlled processing is required, including surface modification, electronics fabrication, and medical sterilization.

·         Application — Wound healing: Wound healing is highlighted as an important application because cold plasma can provide non-invasive antimicrobial treatment and support tissue regeneration.

·         Technology — Direct and remote treatment applications: FMI covers remote treatment, direct treatment, and electrode contact technologies, reflecting the different ways plasma can be delivered across medical and industrial applications.

·         End-user Industry — Medical industry: Healthcare is a major area of application, particularly for sterilization, wound care, antimicrobial treatment, and emerging therapeutic uses.

·         Industrial Application — Electrical & electronic industry: FMI notes significant use of low-pressure plasma for semiconductor etching, deposition, contamination removal, and precision surface modification.

Country-Level Performance

·         USA – 14.2% CAGR (2025–2035): Advanced healthcare infrastructure, plasma-medicine research, industrial electronics and semiconductor applications, government funding, and FDA approvals for medical applications.

·         Japan – 14.0% CAGR (2025–2035): Advanced manufacturing, robotics, semiconductor processing, medical technology research, and government-backed medical-device innovation.

·         South Korea – 13.8% CAGR (2025–2035): Electronics and semiconductor manufacturing, biotechnology, healthcare applications, government spending on medical research, and food sterilization.

·         United Kingdom – 13.7% CAGR (2025–2035): Expanding plasma medicine, wound-care and sterilization applications, sustainability initiatives, and food-processing applications.

1. European Union: FMI separately reports the EU as a market grouping at 13.6% CAGR. It is not included in the country ranking because it is a regional grouping. Growth is linked to stringent environmental regulations, medical research, sustainable technologies, antimicrobial treatments, and food-safety requirements.

2. The USA leads the country-level comparison at 14.2%. FMI attributes the country's expansion to medical-treatment and sterilization applications, research institutions, advanced healthcare infrastructure, electronics manufacturing, semiconductor processing, food safety, government funding, and FDA approvals for medical applications.

3. Japan follows at 14.0%, supported by its advanced manufacturing and medical-technology base. Cold plasma is being applied to semiconductor processing, precision electronics, wound healing, cancer therapy, hospital infection control, and smart textiles.

4. South Korea is projected to grow at 13.8%, with electronics and semiconductor companies adopting plasma for precision surface modification and microelectronics fabrication. Healthcare applications include wound healing, antimicrobial treatment, and dermatology, while food sterilization and packaging provide another area of adoption.

5. The UK records the lowest CAGR among the countries explicitly listed by FMI at 13.7%. The report links its expansion to plasma medicine, wound care, sterilization, sustainable surface treatment, pollution control, food processing, and government initiatives supporting medical-device and clean-energy innovation.

Regional Context

North America is identified as the dominant regional market, with the USA, Canada, and Mexico benefiting from investment in medical applications, plasma-assisted therapies, food safety, packaging, wound-care solutions, sterilization, and cancer research. Supportive regulatory frameworks and collaborations between academia and biotechnology organizations are also identified as growth factors.

Europe represents a sizeable market, led by Germany, France, and the UK in industrial plasma applications and medical research. The European Union's focus on sustainability and energy efficiency is supporting applications in wastewater treatment, air purification, antimicrobial coatings, textile treatment, and automotive coatings.

Asia Pacific is projected to grow rapidly as healthcare expenditure increases alongside semiconductor production, food-safety requirements, advanced manufacturing, and government initiatives supporting medical and industrial plasma applications. China, Japan, South Korea, and India are specifically identified in the regional discussion.

The full report covers North America, Latin America, Europe, Middle East & Africa, East Asia, South Asia, and Oceania, with the detailed forecast covering 30 countries.

Market Drivers, Restraints and Opportunities

Medical sterilization is a central demand driver as hospitals and medical-device processing facilities seek non-thermal treatment methods. FMI also identifies wound-care research as a source of interest because cold plasma can generate reactive oxygen and nitrogen species that support tissue regeneration and reduce bacterial colonization.

Food safety is another application area. Cold plasma can deactivate bacteria, viruses, and fungal spores on packaging and food surfaces without relying on conventional chemical preservatives or high-temperature treatment. The report notes that stricter food-safety regulations and demand for sustainable packaging are supporting interest in these systems.

High equipment costs, limited awareness in developing markets, differences among cold-plasma technologies, and stringent regulatory requirements in healthcare and food-safety applications remain restraints. FMI notes that slow regulatory clearance and limited end-user awareness previously restricted adoption in developing regions.

Opportunities extend into portable cold-plasma devices, AI-integrated plasma systems, wearable electronics, sustainable packaging, textiles, agriculture, wastewater treatment, medical-device sterilization, and plasma-based wound healing and cancer research.

👉 Access the Complete Report in PDF Format:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-12401 

Competitive Landscape

The report's competitive information identifies Adtec Plasma Technology Co., Ltd., Nordson Corporation, Plasmatreat GmbH, Tantec A/S, and Enercon Industries Corporation as the principal companies in its market-share analysis. FMI estimates their respective shares at 18–22%, 14–18%, 12–16%, 10–14%, and 8–12%, with other participants collectively accounting for 26–32%.

The broader company profiles listed on the report page include Linde AG, Nordson Corporation, ADTEC Plasma Technology Co., Ltd., Bovie Medical Corporation, Europlasma NV, Henniker Plasma, Baxter International, Plasmatreat GmbH, Neoplas Tools GmbH, and Ethicon, Inc. The page also identifies Neoplas GmbH, Relyon Plasma GmbH, Vetaphone A/S, Europlasma NV, and Apyx Medical (Bovie Medical) among other regional and emerging participants.

Adtec focuses on medical, antimicrobial, and industrial cold-plasma systems, while Nordson develops cold-atmospheric-plasma solutions for surface treatment and electronic-component processing. Plasmatreat provides plasma cleaning and adhesion technologies, Tantec focuses on surface modification, and Enercon supplies systems for packaging sterilization, polymer bonding, and medical-device processing.

The accessible FMI page does not provide a dated Key Developments section, so no month/year product launches, acquisitions, or regulatory developments have been added.

Analyst Perspective

Sabyasachi Ghosh, Principal Consultant for Healthcare at Future Market Insights, states:

“Cold plasma adoption is expected to broaden as hospitals and manufacturers seek non-thermal treatment methods. Companies able to pair device reliability with application testing are likely to gain stronger buyer confidence.”

Report Scope

The Cold Plasma Market is segmented by:

·         Regime Type: Low-pressure, Atmospheric pressure

·         Application: Wound Healing, Cancer Treatment, Blood Coagulation, Dentistry, Packaging Decontamination, Food Surface Decontamination, Wastewater Treatment, Seed Germination, Other Applications

·         Technology: Remote Treatment, Direct Treatment, Electrode Contact

·         End-user Industries: Medical Industry, Textile Industry, Electrical & Electronic Industry, Food & Agriculture Industry, Other Industries

·         Regions: North America, Latin America, Europe, Middle East & Africa, East Asia, South Asia, Oceania

·         Forecast Period: 2025–2035

·         Countries: 30 countries covered in the detailed forecast

·         Market Size (2025): USD 2,828.0 million
Forecast Value (2035): USD 10,392.6 million
CAGR (2025–2035): 13.9%
Report Price: Starting at US$5,000

Access Full Report: https://www.futuremarketinsights.com/reports/cold-plasma-market

Related Reports:

https://plaza.rakuten.co.jp/fmiinsightd/diary/202610010021/

https://plaza.rakuten.co.jp/fmiinsightd/diary/202610010022/

https://plaza.rakuten.co.jp/fmiinsightd/diary/202610010023/

About Future Market Insights (FMI)

Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales – sales@futuremarketinsights.com
For Media – Rahul.singh@futuremarketinsights.com
For Web – https://www.futuremarketinsights.com